Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 39)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
9-Feb-10 New Constructs, LLC N/A ESRX: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
9-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for ESRX: the economy's impact on ESRX's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Express Scripts Inc. (ESRX) Profile & Health Care Industry Trends Analysis 2010 64 $149 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Insurance Industry Trends, Statistics & Analysis 2010 (Summary) 45 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Insurance Industry Market Research and Competitive Analysis 2010 487 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Outsourcing & Offshoring Industry Market Research and Competitive Analysis 2010 511 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Outsourcing & Offshoring Industry Trends, Statistics & Analysis 2010 (Summary) 47 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract
Next 20

Brokerage Reports (Showing 1 to 2 of 2)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
11-Jan-10 Thomson StreetEvents N/A ESRX - Event Transcript of Express Scripts, Inc. conference call, Jan. 11, 2010 / 8:30am ET 8 $75 View Abstract
30-Mar-09 First Global Le Grand Fromag First Global's Le Grand Fromage: Eats shoots and leaves 6 $30 View Abstract

Independent Reports (Showing 1 to 10 of 37)

Release
Date Contributor Author Title Pages Price More Info
9-Feb-10 New Constructs, LLC N/A ESRX: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
9-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for ESRX: the economy's impact on ESRX's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Express Scripts Inc. (ESRX) Profile & Health Care Industry Trends Analysis 2010 64 $149 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Insurance Industry Trends, Statistics & Analysis 2010 (Summary) 45 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Insurance Industry Market Research and Competitive Analysis 2010 487 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Outsourcing & Offshoring Industry Market Research and Competitive Analysis 2010 511 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Outsourcing & Offshoring Industry Trends, Statistics & Analysis 2010 (Summary) 47 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.